Abstract
Experimental autoimmune encephalomyelitis (EAE) is an autoimmune disease believed to be a model for the human disease multiple sclerosis (MS). Induced by immunizing B10.PL mice with myelin basic protein (MBP), EAE was completely prevented by the administration of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. 1,25-(OH)2D3 could also prevent the progression of EAE when administered at the appearance of the first disability symptoms. Withdrawal of 1,25-(OH)2D3 resulted in a resumption of the progression of EAE. Thus, the block by 1,25-(OH)2D3 is reversible. A deficiency of vitamin D resulted in an increased susceptibility to EAE. Thus, 1,25-(OH)2D3 or its analogs are potentially important for treatment of MS.
Full text
PDF![7861](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c715/38839/b66e3d98cb98/pnas01519-0446.png)
![7862](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c715/38839/27e5bc09ebb5/pnas01519-0447.png)
![7863](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c715/38839/4bb03b445159/pnas01519-0448.png)
![7864](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c715/38839/c67105647235/pnas01519-0449.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bhalla A. K., Amento E. P., Clemens T. L., Holick M. F., Krane S. M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983 Dec;57(6):1308–1310. doi: 10.1210/jcem-57-6-1308. [DOI] [PubMed] [Google Scholar]
- Branisteanu D. D., Waer M., Sobis H., Marcelis S., Vandeputte M., Bouillon R. Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J Neuroimmunol. 1995 Sep;61(2):151–160. doi: 10.1016/0165-5728(95)00076-e. [DOI] [PubMed] [Google Scholar]
- Daynes R. A., Enioutina E. Y., Butler S., Mu H. H., McGee Z. A., Araneo B A. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun. 1996 Apr;64(4):1100–1109. doi: 10.1128/iai.64.4.1100-1109.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeLuca H. F. New concepts of vitamin D functions. Ann N Y Acad Sci. 1992 Sep 30;669:59–69. doi: 10.1111/j.1749-6632.1992.tb17089.x. [DOI] [PubMed] [Google Scholar]
- Deibler G. E., Martenson R. E., Kies M. W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem. 1972;2(2):139–165. doi: 10.1080/00327487208061467. [DOI] [PubMed] [Google Scholar]
- Koeffler H. P., Amatruda T., Ikekawa N., Kobayashi Y., DeLuca H. F. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res. 1984 Dec;44(12 Pt 1):5624–5628. [PubMed] [Google Scholar]
- Lemire J. M., Adams J. S., Sakai R., Jordan S. C. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984 Aug;74(2):657–661. doi: 10.1172/JCI111465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemire J. M., Archer D. C. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991 Mar;87(3):1103–1107. doi: 10.1172/JCI115072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McRae B. L., Vanderlugt C. L., Dal Canto M. C., Miller S. D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 1995 Jul 1;182(1):75–85. doi: 10.1084/jem.182.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller S. D., Karpus W. J. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today. 1994 Aug;15(8):356–361. doi: 10.1016/0167-5699(94)90173-2. [DOI] [PubMed] [Google Scholar]
- Müller K., Odum N., Bendtzen K. 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett. 1993 Feb;35(2):177–182. doi: 10.1016/0165-2478(93)90088-j. [DOI] [PubMed] [Google Scholar]
- Provvedini D. M., Tsoukas C. D., Deftos L. J., Manolagas S. C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983 Sep 16;221(4616):1181–1183. doi: 10.1126/science.6310748. [DOI] [PubMed] [Google Scholar]
- Rigby W. F., Denome S., Fanger M. W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest. 1987 Jun;79(6):1659–1664. doi: 10.1172/JCI113004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross T. K., Darwish H. M., DeLuca H. F. Molecular biology of vitamin D action. Vitam Horm. 1994;49:281–326. doi: 10.1016/s0083-6729(08)61149-8. [DOI] [PubMed] [Google Scholar]
- Smith S. M., Levy N. S., Hayes C. E. Impaired immunity in vitamin A-deficient mice. J Nutr. 1987 May;117(5):857–865. doi: 10.1093/jn/117.5.857. [DOI] [PubMed] [Google Scholar]
- Steinman L. Escape from "horror autotoxicus": pathogenesis and treatment of autoimmune disease. Cell. 1995 Jan 13;80(1):7–10. doi: 10.1016/0092-8674(95)90443-3. [DOI] [PubMed] [Google Scholar]
- Tsoukas C. D., Watry D., Escobar S. S., Provvedini D. M., Dinarello C. A., Hustmyer F. G., Manolagas S. C. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1989 Jul;69(1):127–133. doi: 10.1210/jcem-69-1-127. [DOI] [PubMed] [Google Scholar]
- Yang S., Smith C., Prahl J. M., Luo X., DeLuca H. F. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys. 1993 May 15;303(1):98–106. doi: 10.1006/abbi.1993.1260. [DOI] [PubMed] [Google Scholar]